The protective effects of altered SLC13A5 for osteoporosis proxied by genetic variants (SNPs) appear to contradict to previously published findings in Slc13a5-deficient mice which showed reduced bone mineral density and impaired bone mineralization leading to more fragile bones [8,9]. This evidence concerns the gene SLC13A5 and osteoporosis.